NaturalAntibody has been awarded a grant to support the preparation of a proposal under the Horizon Europe EIC Pre-Accelerator - Widening (HORIZON-WIDERA-2025-02) programme. The project focuses on preparing a full grant application for an AI-based platform for designing optimal drug candidates. The main project deliverable will be the submission of a full application to the European Commission, with the objective of securing funding or receiving the Seal of Excellence. Project value: PLN 110,852.00 EU funding: PLN 110,852.00